Persistent URL of this record https://hdl.handle.net/1887/96299
Documents
-
- Download
- 10.1089-nat.2017.0665
- Not Applicable (or Unknown)
-
open access
In Collections
This item can be found in the following collections:
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
- All authors
- Aartsma-Rus, A.
- Date
- 2017-04-30
- Journal
- Nucleic Acid Therapeutics
- Volume
- 27
- Issue
- 2
- Pages
- 67 - 69